---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284437861.md"
description: "bioAffinity Technologies shares are trading higher after the company announced a pilot study evaluating its tests for chronic obstructive pulmonary disease in collaboration with Brooke Army Medical Center."
datetime: "2026-04-28T18:45:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284437861.md)
  - [en](https://longbridge.com/en/news/284437861.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284437861.md)
---

# 

bioAffinity Technologies shares are trading higher after the company announced a pilot study evaluating its tests for chronic obstructive pulmonary disease in collaboration with Brooke Army Medical Center.

### Related Stocks

- [BIAFW.US](https://longbridge.com/en/quote/BIAFW.US.md)
- [BIAF.US](https://longbridge.com/en/quote/BIAF.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [bioAffinity CyPath Lung Test Sales Surge Sharply](https://longbridge.com/en/news/286117477.md)
- [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)
- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)
- [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md)
- [Regenxbio's muscle disorder therapy meets main goal in late-stage study](https://longbridge.com/en/news/286406339.md)